Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler(Umeå University), Daniel Öhlund(Umeå University), Stina Lindblad(Umeå University), Cédric Patthey(Umeå University), Irina Sarró(Umeå University)
Cited by 57
Related Papers
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
|The Journal of Experimental Medicine|2017|2.4k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Fibroblast heterogeneity in the cancer wound
|The Journal of Experimental Medicine|2014|907
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma
|Modern Pathology|2014|174
Synthetic Prodiginine Obatoclax (GX15‐070) and Related Analogues: Anion Binding, Transmembrane Transport, and Cytotoxicity Properties
|Chemistry - A European Journal|2011|116